Neurocognitive enhancement: what can we do and what should we do?

Nat Rev Neurosci. 2004 May;5(5):421-5. doi: 10.1038/nrn1390.

Authors

Martha J Farah¹, Judy Illes, Robert Cook-Deegan, Howard Gardner, Eric Kandel, Patricia King, Eric Parens, Barbara Sahakian, Paul Root Wolpe

Affiliation

¹ Center for Cognitive Neuroscience, University of Pennsylvania, 3720 Walnut Street, Philadelphia, Pennsylvania 19104, USA. mfarah@psych.upenn.edu

PMID: 15100724
DOI: 10.1038/nrn1390

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Animals
Bioethical Issues* / legislation & jurisprudence
Cognition / drug effects*
Cognition / physiology
Cognition Disorders / drug therapy*
Cognition Disorders / psychology
Humans
Nootropic Agents / pharmacology
Nootropic Agents / therapeutic use

Substances

Nootropic Agents